The ColoCaller, a recent stool-based 4-biomarker panel of methylated NDRG4, SDC2, TFPI2, and WIF1, showed encouraging performance for overall CRC detection with 94.9% (37/39) sensitivity and 98.1% (105/107) specificity. The gene discussed is TFPI2; the disease is colorectal carcinoma.